Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Diabetes Management and Research, Pancreatic function and diabetes, Diabetes and associated disorders, and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
Toward Automation: The Road Traveled and Road Ahead for Integrating Automated Insulin Delivery into Inpatient Care.
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems
Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial
Diabetes Technology Use in Special Populations: A Narrative Review of Psychosocial Factors.
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.
Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System
On the Path toward Expanding Treatment Options for Diabetes.
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Safety Evaluation of the Omnipod® 5 Automated Insulin Delivery System Over Three Months of Use in Children With Type 1 Diabetes (T1D)
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability
Beyond HbA<sub>1c</sub> : using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision-making.
Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery
Multinational Home Use of Closed-Loop Control Is Safe and Effective
Is Psychological Stress a Factor for Incorporation Into Future Closed-Loop Systems?
Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial
Multinight “Bedside” Closed-Loop Control for Patients with Type 1 Diabetes
Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas
Feasibility of Outpatient Fully Integrated Closed-Loop Control